Newspaper Page Text
HEALTH/SCIENCE
The Times, Gainesville, Georgia | gainesvilletimes.com
Thursday, December 20, 2018 7A
Government urges
doctors to write more
overdose antidote Rx
MARY ALTAFFER I Associated Press
A Narcan nasal device which delivers naloxone lies on a counter as a health educator gives
instructions on how to administer it, Tuesday, July 3, in the Brooklyn borough of New York.
FDA reacts to rising opioid death toll
BY CARLA K. JOHNSON
Associated Press
The U.S. government told
doctors Wednesday to con
sider prescribing medica
tions that reverse overdoses
to many more patients who
take opioid painkillers in a
move that could add more
than $1 billion in health
care costs.
Assistant Secretary for
Health Brett Giroir, a doc
tor appointed by President
Donald Trump, announced
the guidance, saying it’s
important for doctors to dis
cuss overdose dangers with
patients.
Prescribing naloxone
such as Narcan along with
opioids forces a conver
sation that will lead to “a
more informed decision by
the patient,” he said.
The action comes a day
after a close vote from a
Food and Drug Administra
tion expert panel endorsing
the idea of rewriting opioid
drug labels to include a
naloxone recommendation
for many or all patients. An
FDA document said such a
move could add more than
$1 billion in health care
costs.
“Even at a billion, it
would be an investment that
is well worth it,” Giroir said.
More than 47,600 Ameri
cans died of opioid over
doses last year, a toll that
has been rising for two
decades. The street drug
fentanyl is the top killer
today, but prescription
painkillers are still a prob
lem, contributing to nearly
15,000 overdose deaths last
year.
The street drug
fentanyl is the
top killer today,
but prescription
painkillers are
still a problem,
contributing to
nearly 15,000
overdose deaths
last year.
Naloxone comes in a
nasal spray, an injection
and an automatic injector.
The Narcan nasal spray
costs about $125 for a two-
dose kit, although govern
ment programs can get
it for less. The automatic
injector can cost as much as
$4,000 per kit, although its
maker recently authorized
a cheaper generic version.
Critics said prescribing
the antidote to pain patients
does not address the grow
ing share of fatal overdoses
caused by illicit opioids, and
could cause shortages for
programs that hand out the
kits to street drug users.
It “will have the unin
tended consequence of
derailing efforts to provide
naloxone to the very effec
tive community programs
we know are successful
in saving lives,” said Dr.
Raeford E. Brown Jr., who
heads an expert panel
advising the FDA.
The new guidance tells
doctors to consider pre
scribing the antidote to
patients on high doses of
opioids, heavy drinkers,
people with sleep apnea
and other breathing prob
lems, people taking benzo
diazepines such as Xanax
and people with addiction
or mental health problems.
It expands upon a similar
recommendation from the
Centers for Disease Control
and Prevention.
In April, U.S. Surgeon
General Jerome Adams
issued the office’s first
national public health advi
sory in 13 years, calling on
more Americans to start
carrying naloxone and urg
ing more federal money to
be dedicated to broadening
access.
Most states allow people
to get naloxone from a
pharmacy or community
program under a statewide
prescription and some
states require doctors to
also prescribe naloxone to
patients on high doses of
opioids.
The FDA is working
toward an over-the-counter
version of naloxone.
Brown said the govern
ment should use its emer
gency authority to buy and
distribute large quantities
of naloxone and imme
diately make it available
over the counter. Trump
directed the health agency
to declare the opioid crisis
a public health emergency
last year.
“That’s the difference
between declaring a public
health emergency and actu
ally acting as if there’s a
public health emergency,”
Brown said.
US adults aren’t getting
taller, just a little heavier
BY MIKE ST0BBE
Associated Press
A closeup of a beam scale, April 3, in New York.
NEW YORK-You don’t
need to hang the mistletoe
higher but you might want to
skip the holiday cookies.
A new report released
Thursday shows U.S. adults
aren’t getting any taller but
they are still getting fatter.
The average U.S. adult is
overweight and just a few
pounds from obese, thanks to
average weight increases in
all groups — but particularly
whites and Hispanics.
Overall, the average
height for men actually
fell very slightly over the
past decade. There was no
change for women.
One factor may be the
shift in the country’s popula
tion. There’s a growing num
ber of Mexican-Americans,
and that group tends to be
a little shorter, said one of
the report’s authors, Cynthia
Ogden of the Centers for Dis
ease Control and Prevention.
The findings come from
a 2015-16 health survey that
measures height and weight.
More than 5,000 U.S. adults
took part.
CDC records date back to
the 1960s, when the average
man was a little over 5 feet,
8 inches tall and weighed
166 pounds. Now, men are
almost 1 inch taller and more
than 30 pounds heavier. But
today’s average height of 5
feet, 9 inches is about a tenth
of an inch shorter than a
decade ago.
The average woman in
the early 1960s was 5 feet, 3
inches and 140 pounds. Now,
women are a half-inch taller
and about 30 pounds heavier,
on average. The average
height is about the same as it
was a decade earlier: 5 feet,
4 inches.
Other survey findings:
■ In the last decade, the
average weight of men rose
about 2 pounds, to 198. For
women, it rose 6 pounds, to
nearly 171.
■ Men have 40-inch waist-
PATRICK SISON I Associated Press
lines, on average. Women’s
waistlines are a little under
39 inches.
■ The average height of
black men and white men
has been holding about
steady, at a little under 5 feet
10.
■ Mexican-American
and Asian-American men
are roughly 3 inches shorter
than whites and blacks, on
average. There was a similar
height gap in women.
■ In 2016, about 18 per
cent of the nation’s popula
tion was Hispanic, up from
about 13 percent in 2000,
according to U.S. Census
figures. Mexican-Americans
account for nearly two-thirds
of the Hispanic population.
PAIDADVERTISEMENT
A New Kind of Sex
Pill Beats Generic
Viagra to the Market
A patented pill costing less than $1 a dose
stands to help millions of men with failing
sex lives; no prescription will be required
Expiring Patent Opens the Door to a New Sex Pill: Vesele
is a new pill that cost just $1 a dose does not require a
prescription. It works on both body and mind to increase
arousal and erection hardness.
SAN DIEGO - A new
sex pill is set to take
the spotlight with the
Viagra patent about to
expire. Since it’s not a
drug, it’s something very
different, it won’t require
a prescription and is
priced just under a $1 a
dose.
The new pill called
Vesele is part of a new
class of performance
enhancers for men,
which work on the body
and mind, supporting
firmer and harder
erections
Formulated with
a special compound
known as a blood flow
boosters, Vesele can
transport its active
ingredients in higher
levels into the blood
stream, where it begins
to work.
The patent pending
ingredient increases
nitric oxide production,
initiating a process
known as vasodilation,
which causes arteries
and vessels throughout
the body to relax. This
allows blood to flow
to penis and genitals,
promoting stronger,
harder erection which
last longer.
But what makes Vesele
so remarkable, and
what these other sex
pills can’t do, is that a
small portion of this
blood flows to the brain,
which creates feelings
of intense arousal. In
laymen’s terms, users
become incredibly
excited and turned on.
This is why the makers
of Vesele say their pill
has worked so effectively
in human clinical use
survey trial. It increases
blood flow to the two
most important organs
for great sex, the penis
and the brain.
The Brain Erection
Connection
Until now, medical
researchers did not fully
understand the brain-
erection connection.
It has now been made
clearer with the data
backing Vesele. When
both are supplied with a
constant blood flow, men
are harder and firmer for
longer...and have higher
sex drives.
“Most of the research
and treatment methods
for men’s sexual
failures have focused
on physiological factors
and have neglected the
emotional ones. For the
leading sex drugs to work,
like Cialis and Viagra, you
need visual stimulation”
explains Dr. Henry Esber,
from the company who
created Vesele.
According to research
published by the National
Institute of Health, 50%
of men taking these drugs
stop responding or can’t
tolerate their side effects...
and on top of that they
spend $25 per pill and it
doesn’t even work half
the time.
This is what makes
Vesele so different. It
provides the blood stream
with nitric oxide which
cause arteries to relax.
The patented accelerator
speeds up this process
even more.
The result is an
increase in hardness
and maintenance and
frequent sex when it is
taken daily.
Great Sex
At Any Age
With the conclusion
of latest human clinical
use survey trial, Vesele
is now being offering in
the US. And regardless of
the market, its sales are
exploding.
Men across the
country are eager to get
their hands on the new
pill and according to the
research, they should be.
In the trial above,
men taking Vesele saw
a staggering 45.1%
improvement in erection
hardness from baseline
over a four-month
period. Their erections
also lasted twice as long.
These same men
also experienced
an astounding 27%
increase in the desire for
sex (libido/sex drive)
and an even greater
improvement in overall
satisfaction and ability
to satisfy their partners.
Higher Absorption
into the Blood
Stream
Vesele is made up
of three specialized
ingredients: two
vasodilators and a
patented absorption
enhancer often called
an accelerator. The FDA
considers all to be safe.
Research shows that
with age, many men
struggle to produce an
erection firm enough for
penetration.
And although there are
many theories as to why
this happens (including
a loss in testosterone)
one thing is certain,
inadequate blood flow
is virtually always to
blame. That’s why sex
drug manufacturers
focus on blood flow,
it makes your erection
hard.
But what’s more
surprising, and what
these manufacturers
have failed to consider,
is that lack of blood flow
can also kill your sex
drive. That’s because
blood supplies energy for
the brain. This energy is
required for creating
brainwaves that cause
excitability and arousal.
Studies show that
nitric oxide stimulates
the entire cardiovascular
system, including the
arteries that lead to both
the brain and penis. The
higher concentration of
the ingredients in Vesele
combined with the
accelerator ensures that
this process continues to
work over time.
The sexual benefits of
Vesele will start to show
as its ingredients build
up in the system over
time. This is why many
men take it every single
day.
The Same Study
Shows Positive
Effects on Women
In the same
outstanding study
referenced throughout,
Vesele was also shown
to have a surprising
effect on women too.
That’s because the same
arteries and vessels that
carry blood and oxygen
to the brain and genitals
are the same in men and
women.
“In our study, women
taking Vesele saw a
stunning 23.7% and
20.4% improvement in
arousal and sex drive
over baseline.
You can imagine
why some couples are
taking Vesele together.
Everything feels better.
Everything works better.
Everyone performs
better.
A New Frontier of
Non-Prescription
Sex Pills
With daily use, Vesele
is helping men (and
women) with their sex
lives and overcome
sexual lets downs
without side effect or
expense.
Through a patented
accelerate, Vesele’s
formula is better
absorbed into the
bloodstream, resulting
in remarkable
improvements in
erection firmness and
hardness.
And with better
blood flow, users also
experienced sexual
feeling they haven’t felt
in years.
Where to Find
Vesele
This is the official
release of Vesele in
Georgia. As such, the
company is offering
a special discounted
supply to any reader
who calls within the next
48 hours.
A special hotline
number and discounted
pricing has been created
for all Georgia residents.
Discounts will be
available starting today
at 6:00 AM and will
automatically be applied
to all callers.
Your Toll-Free Hotline
number is 1-800-749-8316
and will only be open for
the next 48 hours. Only a
limited discounted supply
of Vesele is currently
available in your region.
THESE STATEMENTS HAVE NOT BEEN EVALUATED BY THE U.S. FOOD AND DRUG ADMINISTRATION. THIS PRODUCT IS NOT INTENDED TO
DIAGNOSE, TREAT, CURE OR PREVENT ANY DISEASE. RESULTS N0TTYPICAL. VESELE IS NOT A DRUG AND DOES NOT REPLACE PDE5 INHIBITORS.